⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24549964 | 0.74 | CHEK1 (0.34) | — | |
| Flucytosine SCHEMBL24064 | 0.73 | — | — | |
| SCHEMBL30510082 | 0.73 | — | — | |
| SCHEMBL18081882 | 0.73 | — | — | |
| SCHEMBL7161858 | 0.73 | — | — | |
| SCHEMBL13338331 | 0.73 | — | — | |
| SCHEMBL19363733 | 0.73 | — | — | |
| SCHEMBL18081740 | 0.70 | KMT2A (0.36) | — | |
| SCHEMBL29795706 | 0.70 | KMT2A (0.36) | — | |
| SCHEMBL29551741 | 0.70 | ABL1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2259 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388894-A1 | METHODS OF USING CPG BINDING PROTEINS IN MAPPING MODIFIED CYTOSINE NUCLEOTIDES | ILLUMINA, INC. (US) | 2025-12-25 | — | — | US | claimed |
| EP-4594343-A1 | METHODS OF USING CPG BINDING PROTEINS IN MAPPING MODIFIED CYTOSINE NUCLEOTIDES | Illumina, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4594481-A1 | HELICASE-CYTIDINE DEAMINASE COMPLEXES AND METHODS OF USE | Illumina, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| CN-120153070-A | Helicase-cytidine deaminase complexes and methods of use thereof | 因美纳有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250075176-A1 | COMPOSITIONS COMPRISING HISTONE ACETYLTRANSFERASE INHIBITORS OR REVERSE TRANSCRIPTASE INHIBITORS AND USE THEREOF | FOREVE LABS LTD. (IL) | 2025-03-06 | — | — | US | claimed |
| EP-4490269-A1 | COMPOSITIONS COMPRISING HISTONE ACETYLTRANSFERASE INHIBITORS OR REVERSE TRANSCRIPTASE INHIBITORS AND USE THEREOF | Foreve Labs Ltd. (IL) | 2025-01-15 | — | — | EP | claimed |
| US-20240240244-A1 | Methylation Detection Method and Kit for Genomic DNA or Cell-Free DNA Molecules in Biological Sample | ANCHORDX MEDICAL CO LTD (CN) | 2024-07-18 | — | — | US | claimed |
| WO-2024118592-A2 | METHODS OF USING EXTRACELLULAR VESICLE-ASO TARGETING STAT6 | LONZA SALES AG (CH) | 2024-06-06 | — | — | WO | claimed |
| WO-2024112937-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER AND METABOLIC DISEASE | PRETZEL THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | WO | claimed |
| US-20240167036-A1 | EXTRACELLULAR VESICLE-NLRP3 ANTAGONIST | LONZA SALES AG (CH) | 2024-05-23 | — | — | US | claimed |
| WO-2004094616-A9 | SILENCING TRANSCRIPTION BY METHYLATION | GMR EPIGENETICS (US) | 2005-03-31 | — | — | WO | claimed |
| WO-2004111266-A1 | METHODS FOR GENOME AMPLIFICATION | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2004-12-23 | — | — | WO | claimed |
| WO-2004094616-A2 | SILENCING TRANSCRIPTION BY METHYLATION | GMR EPIGENETICS (US) | 2004-11-04 | — | — | WO | claimed |
| US-20040204380-A1 | Antisense modulation of novel anti-apoptotic bcl-2-related proteins | ACKERMANN ELIZABETH J | 2004-10-14 | — | — | US | claimed |
| WO-2004065625-A1 | ASSAY FOR DETECTING METHYLATION CHANGES IN NUCLEIC ACIDS USING AN INTERCALATING NUCLEIC ACID | HUMAN GENETIC SIGNATURES PTY LTD (AU) | 2004-08-05 | — | — | WO | claimed |
| WO-2004003134-A2 | ANTISENSE INHIBITION VIA RNASE H-INDEPENDENT REDUCTION IN MRNA | ISIS PHARMACEUTICALS, INC. (US) | 2004-01-08 | — | — | WO | claimed |
| US-20040006036-A1 | Silencing transcription by methylation | GMR, A DELAWARE CORPORATION | 2004-01-08 | — | — | US | claimed |
| EP-1325955-A1 | Compounds and methods for the identification and/or validation of a target | atugen AG (DE) | 2003-07-09 | — | — | EP | claimed |
| US-6001992-A | OLIGONUCLEOTIDES WHICH PROMOTE APOPTOSIS; ANTICARCINOGENIC AGENTS, VIRICIDES, AND TREATMENT OF AUTOIMMUNE DISORDERS | ISIS PHARMACEUTICALS INC. (US) | 1999-12-14 | — | — | US | claimed |
| EP-0133473-B1 | In vivo labelling of polynucleotide sequences | ENZO BIOCHEM INC (US) | 1994-03-23 | — | — | EP | claimed |